VOR Vor Biopharma Inc.
NEUTRAL
Impact: 2/10
DEFA14A
Proxy solicitation materials
Latest settled — T+20d ⚠ clustered
VOR ▼ -1.95% at T+20d
NEUTRAL call ✗ call lost -1.95% · α vs SPY -7.42% · entry $14.38 → $14.10
Last close $14.36 (close Jun 12) · -0.14% from $14.38 entry
T+1d
-1.88%
call -1.88% · α -1.87%
$14.11
settled 7w ago
T+5d
+2.29%
call +2.29% · α +0.60%
$14.71
settled 6w ago
T+20d
-1.95%
call -1.95% · α -7.42%
$14.10
settled 20d ago
T+60d
—
call — · α —
—
in 5w
Price Chart
Loading chart...
Executive Summary
Analysis based on filing metadata only — document content was unavailable. Vor Biopharma filed a DEFA14A (additional definitive proxy soliciting materials) on April 27, 2026. Without readable content, the specific proposals or solicitation details cannot be assessed.
Actionable Insight
No actionable content available from this filing. Monitor future filings for proxy details or a readable definitive proxy statement.
Key Facts
- Form DEFA14A filed by Vor Biopharma Inc. (VOR) on April 27, 2026
- Filing relates to proxy solicitation materials under Rule 14a-12
- Document content is not readable (binary/encoded)
- Market cap ~$675M; recent insider selling of $41.6M over 30 days
Financial Impact
Not determinable from unavailable content
Risk Factors
- Lack of transparency due to unreadable filing
- Potential material information missed without readable document
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
85% bullish (13 analysts)
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-181892 |
| Document: 0001193125-26-181892-index-headers.html | 0001193125-26-181892 |
| Document: 0001193125-26-181892-index.html | 0001193125-26-181892 |
| Document: 0001193125-26-181892.txt | 0001193125-26-181892 |
7 reports for VOR
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
3d ago
|
Institutional Cluster
| $13.00 awaiting T+20 | awaiting T+20 | — | $14.36 (+10.46%) |
|
Jun 8, 2026
6d ago
|
Press Release
| $13.10 awaiting T+20 | awaiting T+20 | — | $14.36 (+9.62%) |
|
May 7, 2026
5w ago
|
EFFECT
| $16.08 $13.44 | ▼ −16.42% | ▼ −19.55% | $14.36 (−10.70%) |
|
Apr 27, 2026
6w ago
|
S-3
| $14.38 $14.10 | ▼ −1.95% | ▼ −7.42% | $14.36 (−0.14%) |
|
Apr 27, 2026
6w ago
|
DEFA14A
| $14.38 $14.10 | ▼ −1.95% | ▼ −7.42% | $14.36 (−0.14%) |
|
Mar 27, 2026
11w ago
|
Press Release
| $14.48 $14.12 | ▼ −2.49% | ▼ −15.23% | $14.36 (−0.83%) |
|
Mar 23, 2026
11w ago
|
Press Release
| $12.15 $15.32 | ▲ +26.09% | ▲ +17.19% | $14.36 (+18.19%) |
Showing 7 of 7
US Market Status
Market Closed — Opens in 4h 33m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access